account_balanceBalance Sheet (BS) Summary

Updated: 06/30/20262026 Q2

Total Assets

264.6M USD

YoY +36.0%

Shareholders' Equity

239.2M USD

YoY +42.5%

Equity Ratio

90.4%

YoY +4.1pt

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %

200150100500

2021

2022

2023

2024

2025

Balance Sheet Details

Unit: USD

Item

2019

2020

2021

2022

2023

2024

2025

Cash

Cash and Equivalents

Short-term Investments

Net Receivables

Inventory

Other Current Assets

Total Current Assets

226.65M

90.33M

88,000

0

6.60M

323.67M

Goodwill

Intangible Assets

Property, Plant and Equipment

Property, Plant and Equipment Net

Long-term Investments

Other Assets

Other Non-current Assets

Net Tangible Assets

Non-current Assets Total

Total Assets

0

5.49M

0

3.48M

332.64M

8.97M

332.64M

Accounts Payable

Short-term Debt

Short/Current Long-term Debt

Current Deferred Revenue

Other Current Liabilities

Total Current Liabilities

3.52M

0

10.05M

22.69M

Long-term Debt

Long-term Debt Total

Capital Lease Obligations

Other Non-current Liabilities

Net Debt

Non-current Liabilities Total

Total Liabilities

4.70M

5.96M

1.26M

0

-220.69M

4.70M

27.39M

Common Stock

Common Stock Shares Outstanding

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Other Stockholder Equity

Treasury Stock

Total Stockholder Equity

11,000

94.57M

1.06B

-751.43M

404,000

0

305.26M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan

Amylyx Pharmaceuticals, Inc.

account_balanceBalance Sheet (BS) Summary

Asset & Liability Mix

Equity Ratio Trend (5 Years)

Balance Sheet Details

Unlock Long-Term Balance Sheet Data